- Home
- JMSB vs CRVS Comparison
JMSB vs CRVS Comparison
Compare JMSB & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMSB
- CRVS
- Stock Information
- Founded
- JMSB 2005
- CRVS 2014
- Country
- JMSB United States
- CRVS United States
- Employees
- JMSB N/A
- CRVS N/A
- Industry
- JMSB Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- JMSB Finance
- CRVS Health Care
- Exchange
- JMSB Nasdaq
- CRVS Nasdaq
- Market Cap
- JMSB 282.0M
- CRVS 305.4M
- IPO Year
- JMSB N/A
- CRVS 2016
- Fundamental
- Price
- JMSB $18.99
- CRVS $5.43
- Analyst Decision
- JMSB Buy
- CRVS Strong Buy
- Analyst Count
- JMSB 2
- CRVS 4
- Target Price
- JMSB $22.50
- CRVS $15.00
- AVG Volume (30 Days)
- JMSB 15.4K
- CRVS 483.4K
- Earning Date
- JMSB 07-23-2025
- CRVS 08-07-2025
- Dividend Yield
- JMSB 1.58%
- CRVS N/A
- EPS Growth
- JMSB 688.28
- CRVS N/A
- EPS
- JMSB 1.32
- CRVS N/A
- Revenue
- JMSB $56,750,000.00
- CRVS N/A
- Revenue This Year
- JMSB N/A
- CRVS N/A
- Revenue Next Year
- JMSB N/A
- CRVS N/A
- P/E Ratio
- JMSB $14.39
- CRVS N/A
- Revenue Growth
- JMSB 59.00
- CRVS N/A
- 52 Week Low
- JMSB $13.81
- CRVS $2.54
- 52 Week High
- JMSB $26.52
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- JMSB 50.78
- CRVS 71.05
- Support Level
- JMSB $18.85
- CRVS $4.05
- Resistance Level
- JMSB $19.75
- CRVS $5.05
- Average True Range (ATR)
- JMSB 0.44
- CRVS 0.29
- MACD
- JMSB 0.02
- CRVS 0.09
- Stochastic Oscillator
- JMSB 56.07
- CRVS 96.39
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).